MedAvail Holdings (MedAvail Holdings) COGS-to-Revenue : 0.56 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is MedAvail Holdings COGS-to-Revenue?

MedAvail Holdings's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.23 Mil. Its Revenue for the three months ended in Jun. 2023 was $0.41 Mil.

MedAvail Holdings's COGS to Revenue for the three months ended in Jun. 2023 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. MedAvail Holdings's Gross Margin % for the three months ended in Jun. 2023 was 43.95%.

MedAvail Holdings COGS-to-Revenue Historical Data

The historical data trend for MedAvail Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAvail Holdings COGS-to-Revenue Chart

MedAvail Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

0.75

0.63

0.99

0.94

MedAvail Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial										0.62	0.89	1.01	0.59	0.56

MedAvail Holdings COGS-to-Revenue Calculation

MedAvail Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	40.524	/	43.109
	=	0.94

MedAvail Holdings's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.227	/	0.405
	=	0.56

MedAvail Holdings (OTCPK:MDVLQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

MedAvail Holdings's Gross Margin % for the three months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.227 / 0.405
	=	43.95 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

MedAvail Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of MedAvail Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MedAvail Holdings (MedAvail Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (OTCPK:MDVLQ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040

Website

https://www.medavail.com

MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.

Executives

Ramona Seabaugh	officer: Chief Financial Officer	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Michael R Kramer	director	3910 BRICKWAY BLVD, SANTA ROSA CA 95403
Paul D Johnson	director	440 N BARRANCA AVE #3550, COVINA CA 91723
Glen D. Stettin	director	C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121
Mark Edward Doerr	director, officer: Chief Executive Officer	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Abg Wtt-medavail Ltd	10 percent owner	15 QUEENS ROAD CENTRAL, UNIT 3002-3004, 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK, HONG KONG F4 0000000000
Redco Ii Master Fund, L.p.	director, 10 percent owner	ONE LETTERMAN DRIVE, BLDG D, STE D3-300, SAN FRANCISCO CA 94129
Alyeska Fund Gp, Llc	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, Llc	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investments, Llc	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Anand Parekh	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Master Fund, L.p.	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, L.p.	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Steven Hess	officer: Executive Vice President	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Edwin Kilroy	director, officer: Chief Executive Officer	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4